---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-003900"
form_type: "8-K"
ticker: "ANIK"
cik: "0000898437"
company_name: "Anika Therapeutics, Inc."
filed_at: "2024-07-11T23:59:59+00:00"
generated_at: "2026-05-31T21:57:46.797271+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Anika Therapeutics stockholders elect directors and ratify auditor at 2024 annual meeting

## Summary
- Elected Sheryl L. Conley, William R. Jellison, Stephen O. Richard as Class I directors (2027 term).
- Ratified Deloitte & Touche LLP as independent auditor: 12,337,376 for, 43,654 against.
- Say-on-pay proposal passed on a non-binding advisory basis: 11,020,273 for, 129,717 against.
- Annual meeting turnout: 12,387,064 shares voted, representing 83.37% of entitled voting power.
- No contested solicitations; all board proposals carried with substantial majority support.

## SEC filing metadata
- accession: 0001171843-24-003900
- form_type: 8-K
- ticker: ANIK
- cik: 0000898437
- company_name: Anika Therapeutics, Inc.
- filed_at: 2024-07-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/898437/000117184324003900/0001171843-24-003900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/898437/000117184324003900/f8k_071124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-003900
- JSON: https://secwatch.observer/filing/0001171843-24-003900.json
- Plain text: https://secwatch.observer/filing/0001171843-24-003900.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.